On November 5, 2007 the FDA requested Bayer Pharmaceuticals Corp to suspend the further sale or use of the antibleeding drug called Trasylol, amid growing concerns and strong medical evidence that Trasylol may be linked to a higher risk of kidney and renal failures, heart attacks, stroke and death than other antibleeding drugs used during a cardiac bypass, heart catherization or other cardiac surgery or operations.
Trasylol (aprotinin), Bayer’s injectable drug used to prevent excessive blood loss during heart surgery, has produced distrubing results in a recent New England Journal of Medicine study. The New England Journal of Medicine, January 25, 2006, states that patients who were given Trasylol, compared with controls, had nearly double the risk of death, renal failure, or stroke and a more than 50% increased risk of heart attack. Trasylol also increases the risk of kidney damage and kidney failure. If you or a loved one have experienced complications after cardiopulmonary bypass (CPB) or coronary artery bypass graft surgery (CABG), or any serious surgery, you should contact your medical providers to determine if Trasylol was used during the procedure.
Speak to a Trasylol Lawyer
If you or a loved one has suffered a heart attack, heart damage, stroke or kidney failure after Trasylol was used during heart surgery, contact our law firm at once. It may be too late to recover from the debilitating effects of Trasylol, but an experienced product liability attorney can assist you in a legal action against the makers of Trasylol. You are not alone. Join other heart attack, heart damage, stroke and kidney failure victims in speaking up and fighting for their legal rights. You may be entitled to file a lawsuit for your pain and suffering, mental anguish, medical bills and other legal remedies and damages. Contact our law firm today.
For more information: Heart Attack, Kidney Problems, Stroke, Trasylol